About Us

One clear goal: To bring a Data Science approach to the medical world.

Let's meet

Our Team:

Dr. Alexandru Floares, CEO, founder, biomedical AI expert

Dr. Carmen Floares, CSO, founder, oncologist

Adrian Zety, CTO,  bioinformatics & molecular biology

Dalibor Hrask, bioinformatics & programmer

Brandusa Bitel, Clinical Specialist

AIE's CEO and founder:

Alexandru Floares, MD, PhD

He holds an MD and PhD degree in Biophysics, from the Grigore T. Popa University of Medicine and Pharmacy, Iași, Romania. Working for several years as a clinical neurologist, he resigned to follow his dream: to work on AI-based solutions for diagnosis and prognosis as well as optimization and individualization of therapeutic strategies. For this purpose, he founded SAIA in 2004.

In 2008, Dr. Floares teamed up with the world renowned MD Anderson Cancer Center, starting a project for bladder cancer diagnostic, based on circulating miRNA and AI. The results were impressive, leading to the filling of a Romanian patent application together with the University of Medicine and Pharmacy from Cluj-Napoca, Romania. In 2013, MD Anderson Cancer Center and Dr. Floares extended their project to include colorectal cancer and the enormous diagnostic potential of the system became clear.

Prof. Dr. George Calin, cancer biology

In addition to our team

Meet our advisers:

Prof. Dr. Florin Manolache, HPC and parallel computing

Aie's Advisor

George Calin, MD, PhD

He is Professor at the Department of Experimental Therapeutics and Co-Director of The RNA Interference and Non-coding RNA Center, at The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Furthermore, he is Professor at the Department of Leukemia, Division of Cancer Medicine, within the same institute. Dr. Calin received both his M.D. and Ph.D. degrees at Carol Davila University of Medicine in Bucharest, Romania.

Dr. Calin was the first to discover the relationship between microRNA and cancer and published a seminal paper (> 5000 citations) in 2002. He opened and led an entirely new field of research and now is clear that miRNA is causally involved in oncogenesis, and likely to be the most informative molecular category for cancer diagnosis and screening.

Aie's Advisor

Antonio Ornelas-Soares, PhD

Dr. Ornelas-Soares, an AIE advisor, is a serial entrepreneur exploring the intersection of Health Sciences and Technology through Business Entrepreneurship. He is a results-driven international Health and Medical Devices Executive and an entrepreneur with a proven track record in strategy development and implementation, business development, and commercial analyses. He has extensive experience in international settings and in merger & acquisition related issues. He held general management roles at both corporate and business unit levels at top-tier firms and is an experienced CEO for Deep Tech-based start-ups. Dr. Ornelas-Soares advises AIE on effective strategic and operational issues.

contact information


Send your questions to us !